This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
When Does Market Timing Actually Work? - November 01, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Electronics Testing Equipment Outlook: Solid Demand Ahead
by Zacks Equity Research
Increasing usage of electronic testing equipment and solutions in the devices required in every major sector continues to be a tailwind for Zacks Electronics - Testing Equipment industry.
Advanced Energy (AEIS) Supplies Power to Grenzebach's Lab
by Zacks Equity Research
Advanced Energy Industries (AEIS) collaborates with Grenzebach Group to supply power to the latter's new lab.
Cypress Looks to Gain Traction With New USB-C Controller
by Zacks Equity Research
Cypress Semiconductor (CY) launches an advanced USB-C controller called ACG1F to make the most of the opportunities in the market.
Trimble Strengthens Agriculture Portfolio with Weedseeker 2
by Zacks Equity Research
Trimble (TRMB) launches an Advanced Spray System called Weedseeker 2 with an aim to gain traction among farmers.
Agilent Boosts Spectroscopy Share With New Facility in UK
by Zacks Equity Research
Agilent Technologies (A) opens a new facility in U.K. for research and development in the field of spectroscopy.
How to Time the Markets Like an Investing Pro - October 10, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Bruker To Buy Freiberg Instruments' Magnettech EPR Business
by Zacks Equity Research
The Freiberg Instruments' Magnettech EPR business acquisition is expected to boost Bruker's (BRKR) BioSpin business by complementing its existing range of EPR offerings.
4 Stocks to Focus on Global Biotechnology Reagents Market
by Zacks Equity Research
Increased use of reagents in the field of research, bioscience and genetics is pushing the biotechnology reagents market higher.
Simple Market Timing Strategies That Work - September 17, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
What Makes Agilent (A) a New Buy Stock
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Agilent (A) Up 11.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent Technologies (A) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent Prices Public Offering of $500M Senior Notes Due 2029
by Zacks Equity Research
Agilent (A) prices senior notes aggregating $500 million. These notes carry an interest rate of 2.750%.
Trimble Strengthens Forestry Division With 3LOG Acquisition
by Zacks Equity Research
3LOG Systems' solutions complement will Trimble's (TRMB) Connected Forest solutions portfolio.
Simple Market Timing Strategies That Work - August 21, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (A) Outperforming Other Computer and Technology Stocks This Year?
Agilent Launches eSight, Expands Cell Analysis Portfolio
by Zacks Equity Research
Agilent (A) unveils a multimode real-time cell analyzer, which will aid in expanding its presence in the research areas of cell biology, immunology, immuno-oncology and immunotherapy.
Tencent (TCEHY) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Tencent's (TCEHY) second-quarter 2019 results benefit from robust FinTech and Business Services revenues despite sluggish ad environment in China.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Agilent (A) Jumps: Stock Rises 6.1%
by Zacks Equity Research
Agilent (A) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Agilent (A) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
Agilent (A) reports solid fiscal third-quarter results driven by strength in all its revenue segments.
Agilent Technologies (A) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 5.56% and 2.85%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Tumbles Following Yield Curve Inversion
by Zacks Equity Research
Wall Street Tumbles Following Yield Curve Inversion
Stock Futures Plunge as Recession Fears Intensify
by Zacks Equity Research
U.S. stock futures plummeted ahead of trading on Wednesday after a key Treasury yield curve inverted signaling an impending recession.